GO:1905828 regulation of prostaglandin catabolic process: Catabolic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905828 (regulation of prostaglandin catabolic process) is a biological_process term defined as any process that modulates the frequency, rate or extent of prostaglandin catabolic process.
• Prostaglandin catabolism controls the lifetime and local concentration of bioactive prostaglandins, and its dysregulation is linked to inflammation, vascular permeability, renal physiology and metabolic disease [2,3,6,7].
• Prostaglandin transport proteins such as SLCO2A1 determine substrate access to catabolic enzymes, making transport a key regulatory node in prostaglandin degradation [3,5].
• Post-transcriptional control, including microRNA and AU-rich element (ARE)-mediated mRNA regulation, modulates the expression of prostaglandin pathway enzymes and thereby influences catabolic flux.
• Inter-organ prostaglandin signaling can regulate systemic insulin sensitivity independently of UCP1, highlighting the metabolic importance of prostaglandin turnover.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of candidate regulators of prostaglandin catabolism in relevant cell types [1,4,5].
Description
Prostaglandins are lipid mediators derived from arachidonic acid that act locally to regulate inflammation, vascular tone, renal function and metabolic homeostasis [2,3,7]. Their biological effects depend not only on synthesis but also on the rate at which they are catabolized, because catabolism determines the half-life and steady-state concentration of these short-lived molecules [3,4]. The Gene Ontology term GO:1905828, regulation of prostaglandin catabolic process, captures the regulatory inputs that modulate the frequency, rate or extent of prostaglandin breakdown [2,3]. Understanding this term is important because altered prostaglandin catabolism contributes to pathological states ranging from impaired vascular permeability to metabolic dysfunction [1,6]. Mechanistically, prostaglandin catabolism involves enzymatic oxidation and transport-mediated uptake, and its regulation occurs at multiple levels including transporter availability, enzyme expression and post-transcriptional control [3,4,5]. For example, the prostaglandin transporter SLCO2A1 mediates cellular uptake of prostaglandins, a step that can limit or facilitate their degradation [3,5]. In addition, microRNAs and AU-rich elements can regulate the stability of mRNAs encoding prostaglandin pathway components, indirectly influencing catabolic capacity. For researchers, GO:1905828 provides a structured framework to annotate and interrogate the regulatory mechanisms that control prostaglandin clearance. This article summarizes the definition, biological context, key genes, disease links and experimental strategies relevant to this term, with all factual statements supported by published literature [1-8].
regulation of prostaglandin catabolic process At A Glance
| GO ID | GO:1905828 |
|---|---|
| GO term | regulation of prostaglandin catabolic process |
| Ontology | biological_process |
| Synonym | regulation of prostaglandin breakdown; regulation of prostaglandin catabolism; regulation of prostaglandin degradation |
| Major function | Modulates the frequency, rate or extent of prostaglandin catabolic process |
| Related process | Prostaglandin catabolic process (GO:0006693) |
| Regulates | Prostaglandin catabolic process |
| Taxon range | Eukaryota |
| Definition source | QuickGO |
What Is GO:1905828?
GO:1905828, regulation of prostaglandin catabolic process, is a biological_process term defined as any process that modulates the frequency, rate or extent of prostaglandin catabolic process. In other words, it encompasses the molecular and cellular events that adjust how quickly prostaglandins are broken down, including changes in the activity, abundance or localization of catabolic enzymes and transporters [2,3,5].
Why Is regulation of prostaglandin catabolic process Important in Cell Biology?
Regulation of prostaglandin catabolism is critical because prostaglandins are locally acting mediators with short half-lives, and their biological effects are tightly controlled by the balance between synthesis and degradation [2,3]. Dysregulated prostaglandin catabolism has been implicated in inflammatory diseases, vascular permeability disorders, renal physiology and systemic metabolic regulation [1,6,7]. Studying GO:1905828 helps researchers identify the molecular checkpoints that determine prostaglandin clearance and evaluate them as potential therapeutic targets [4,5].
• Controls the duration and intensity of prostaglandin signaling in inflammation and type 2 immunity.
• Regulates vascular permeability through prostanoid-mediated mechanisms.
• Influences renal prostaglandin homeostasis and kidney function.
• Modulates systemic insulin sensitivity via inter-organ prostaglandin signaling.
• Determines local prostaglandin concentrations through transporter-mediated uptake [3,5].
• Provides a framework for annotating genes involved in prostaglandin degradation [2,4].
• Links post-transcriptional regulation (microRNAs, AREs) to lipid mediator turnover.
• Supports drug discovery targeting prostaglandin catabolic pathways [2,5].
• Enables CRISPR-based causal testing of candidate regulatory genes [1,4,5].
• Facilitates cross-species comparison of prostaglandin clearance mechanisms [3,7].
What Happens During regulation of prostaglandin catabolic process?
Substrate availability and transport
In simple terms: Before prostaglandins can be broken down, they must be taken up into cells.
Prostaglandin catabolism begins with the availability of prostaglandins to catabolic enzymes, a step influenced by transport proteins such as SLCO2A1, which mediates cellular uptake of prostaglandins [3,5]. The structure and transport mechanism of SLCO2A1 have been characterized, revealing how this transporter recognizes and translocates prostaglandins across membranes. Regulation of transporter expression or activity therefore directly modulates the rate of prostaglandin catabolism.
Enzymatic degradation
In simple terms: Enzymes chemically modify prostaglandins to inactivate them.
Once inside the cell, prostaglandins undergo enzymatic oxidation, primarily via 15-hydroxyprostaglandin dehydrogenase (15-PGDH) and related enzymes, leading to their inactivation [2,4]. The expression and activity of these enzymes are regulated at multiple levels, including transcriptional and post-transcriptional mechanisms. This enzymatic step is a key determinant of prostaglandin half-life and biological potency.
Post-transcriptional regulation of catabolic machinery
In simple terms: Cells can adjust the amount of degradation enzymes by controlling their mRNA stability.
MicroRNAs and AU-rich elements (AREs) in the 3' untranslated regions of mRNAs encoding prostaglandin pathway components can regulate mRNA stability and translation, thereby influencing catabolic capacity. This layer of regulation allows rapid adjustments in prostaglandin degradation in response to inflammatory or metabolic signals.
Integration with systemic metabolism
In simple terms: Prostaglandin breakdown in one tissue can affect whole-body metabolism.
Inter-organ prostaglandin signaling, regulated by m6A mRNA methylation in brown fat, can influence systemic insulin sensitivity independently of UCP1. This demonstrates that regulation of prostaglandin catabolism is not confined to local inflammation but can have systemic metabolic consequences.
Feedback and cross-talk with synthesis
In simple terms: The rate of prostaglandin breakdown is balanced against how fast prostaglandins are made.
Regulation of prostaglandin catabolism is coordinated with prostaglandin synthesis to maintain appropriate tissue levels of these mediators [2,3]. In microglial cells, prostanoid synthesis is regulated, and prostaglandin E2 can affect microglial functions, illustrating feedback between synthesis, action and degradation. Such cross-talk ensures that prostaglandin signaling is appropriately terminated.
Key Genes Involved in GO:1905828 regulation of prostaglandin catabolic process
The following genes and proteins have been implicated in prostaglandin catabolism or its regulation, based on published literature [1-8].
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLCO2A1 | Prostaglandin transporter mediating cellular uptake | Regulates substrate access to catabolic enzymes; target for transport studies [3,5] |
| HPGD | 15-hydroxyprostaglandin dehydrogenase, primary prostaglandin-degrading enzyme | Key catabolic enzyme; regulates prostaglandin half-life [2,4] |
| PTGS2 | Cyclooxygenase-2, prostaglandin synthesis | Synthesis enzyme whose balance with catabolism affects prostaglandin levels [2,4] |
| PTGS1 | Cyclooxygenase-1, prostaglandin synthesis | Constitutive synthesis enzyme contributing to prostaglandin pool |
| PTGES | Prostaglandin E synthase | Synthesis of PGE2, a major substrate for catabolism [2,8] |
| ABCC4 | Multidrug resistance protein 4, prostaglandin efflux transporter | Affects extracellular prostaglandin levels and catabolism |
| SLC22A8 | Organic anion transporter, prostaglandin transport | Contributes to prostaglandin uptake and clearance |
| CBR1 | Carbonyl reductase 1, prostaglandin metabolism | Alternative catabolic pathway for prostaglandins |
| AKR1C3 | Aldo-keto reductase family 1 member C3, prostaglandin metabolism | Metabolizes prostaglandins and affects signaling |
| PTGFR | Prostaglandin F receptor | Mediates effects of prostaglandins, influencing feedback |
| PTGER2 | Prostaglandin E receptor 2 | Modulates PGE2 signaling and catabolic feedback |
| PTGER4 | Prostaglandin E receptor 4 | Involved in inflammation and immune regulation |
| METTL3 | m6A methyltransferase | Regulates m6A methylation in brown fat affecting prostaglandin signaling |
| METTL14 | m6A methyltransferase subunit | Part of m6A writer complex influencing prostaglandin axis |
| FTO | m6A demethylase | Modulates m6A methylation and prostaglandin signaling |
| ALKBH5 | m6A demethylase | Affects m6A-dependent regulation of prostaglandin pathways |
| AGO2 | Argonaute 2, microRNA effector | Mediates microRNA regulation of prostaglandin pathway mRNAs |
| DICER1 | MicroRNA processing enzyme | Required for microRNA-mediated regulation of prostaglandin synthesis |
How Is regulation of prostaglandin catabolic process Regulated?
Regulation of prostaglandin catabolic process is controlled at multiple levels. Transport-mediated uptake via SLCO2A1 and other transporters determines substrate availability for degrading enzymes [3,5]. Enzymatic activity of 15-PGDH and related enzymes is regulated transcriptionally and post-transcriptionally, including by microRNAs and AU-rich elements. Systemic signals such as m6A mRNA methylation in brown fat can influence inter-organ prostaglandin signaling and insulin sensitivity. Additionally, prostaglandin synthesis and catabolism are coordinately regulated to maintain appropriate mediator levels [2,8].
regulation of prostaglandin catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLCO2A1 | Prostaglandin transport and clearance disorders | Knockout of SLCO2A1 in HEK293 or HeLa cells followed by prostaglandin uptake assays |
| HPGD | Inflammation and prostaglandin degradation defects | CRISPR knockout of HPGD in macrophages or fibroblasts, measure PGE2 levels [2,4] |
| METTL3 | Metabolic syndrome and insulin resistance | Brown adipocyte-specific knockout in mice, assess insulin sensitivity |
| PTGS2 | Cancer inflammation and tumor progression | Knockout in cancer cell lines, measure prostaglandin production and catabolism |
| AGO2 | MicroRNA-mediated regulation in cancer | Knockout in cancer cells, assess prostaglandin pathway mRNA stability |
Inflammation and vascular disorders
Prostaglandins are key mediators of inflammation and vascular permeability, and their catabolism determines the duration of their effects [2,6]. Dysregulated prostaglandin degradation can prolong inflammatory responses and contribute to vascular permeability disorders. Targeting catabolic pathways is therefore of therapeutic interest in inflammatory diseases.
Metabolic disease and insulin resistance
Inter-organ prostaglandin signaling regulated by m6A methylation in brown fat affects systemic insulin sensitivity independently of UCP1. This links regulation of prostaglandin catabolism to metabolic diseases such as insulin resistance and type 2 diabetes.
Renal physiology and disease
Renal prostaglandins play important roles in kidney function, and their catabolism influences renal hemodynamics and salt handling. Alterations in prostaglandin degradation may contribute to renal pathophysiology.
Cancer and microRNA regulation
MicroRNAs and AU-rich elements regulate prostaglandin synthesis, and their dysregulation has been implicated in cancer progression. Because catabolism controls prostaglandin levels, its regulation may influence tumor inflammation and angiogenesis.
From regulation of prostaglandin catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLCO2A1 alter prostaglandin catabolism? | SLCO2A1 knockout cell line (e.g., HEK293) |
| Does HPGD mutation affect prostaglandin half-life? | HPGD point-mutation knock-in in relevant cells [2,4] |
| Does m6A modification regulate prostaglandin signaling? | METTL3 knockout or knock-in in brown adipocytes |
| Does microRNA regulation affect prostaglandin synthesis? | AGO2 knockout or DICER1 knockout cells |
| Does overexpression of a transporter increase prostaglandin uptake? | SLCO2A1 overexpression in cell lines [3,5] |
| Does prostaglandin catabolism affect vascular permeability? | Endothelial cell knockout models |
How to Study the regulation of prostaglandin catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function effects on prostaglandin catabolism | Identify novel regulators [1,4] |
| Lipidomics / mass spectrometry | Prostaglandin and metabolite levels | Quantify catabolic flux |
| Transport uptake assay | Prostaglandin transport activity | Characterize SLCO2A1 variants |
| RNA-seq | Gene expression changes | Assess transcriptional regulation |
| MicroRNA profiling | microRNA expression | Link microRNAs to prostaglandin pathway |
| ARE reporter assay | mRNA stability mediated by AU-rich elements | Study post-transcriptional control |
| Western blot | Protein levels of catabolic enzymes | Validate knockout or overexpression |
| Enzyme activity assay | 15-PGDH activity | Measure catabolic capacity |
CRISPR-based genetic screens
CRISPR knockout screens can identify genes that regulate prostaglandin catabolism by measuring prostaglandin levels or catabolic enzyme activity [1,4]. Libraries targeting transporters, enzymes and regulatory factors enable unbiased discovery.
Biochemical assays for prostaglandin degradation
Enzymatic assays using purified 15-PGDH or cell lysates can measure prostaglandin catabolic rates [2,4]. Mass spectrometry-based lipidomics quantifies prostaglandin species and their metabolites.
Transport assays
Radiolabeled or fluorescent prostaglandin uptake assays in cells expressing wild-type or mutant SLCO2A1 can measure transport kinetics and its impact on catabolism [3,5].
Transcriptomic and post-transcriptional analysis
RNA-seq and microRNA profiling can reveal changes in mRNAs encoding prostaglandin pathway components, while ARE reporter assays assess post-transcriptional regulation.
How CRISPR Can Be Used to Study GO:1905828 regulation of prostaglandin catabolic process
Knockout
CRISPR knockout of genes such as SLCO2A1, HPGD or METTL3 can reveal their causal roles in prostaglandin catabolism [1,5]. Knockout cell lines are valuable for measuring changes in prostaglandin levels and catabolic rates [2,4].
Point Mutation
Introducing point mutations in genes like SLCO2A1 can model human variants and test their effects on transport and catabolism. Point-mutation knock-in models help dissect structure-function relationships.
Knock-in
Knock-in of tagged or reporter alleles allows tracking of catabolic enzymes and transporters in live cells [3,5]. This approach can visualize prostaglandin degradation dynamics.
Overexpression
Overexpression of catabolic enzymes or transporters can enhance prostaglandin clearance and test sufficiency in regulating catabolism [2,3]. Such models are useful for drug screening and pathway validation.
How EDITGENE Supports regulation of prostaglandin catabolic process Research
Researchers studying regulation of prostaglandin catabolic process-related genes often need to determine whether a candidate gene is causally involved in prostaglandin degradation or its regulation. EDITGENE provides CRISPR-based cell model services to enable such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for regulation of prostaglandin catabolic process research.
Frequently Asked Questions About regulation of prostaglandin catabolic process
What is GO:1905828?
GO:1905828 is the Gene Ontology term for regulation of prostaglandin catabolic process, defined as any process that modulates the frequency, rate or extent of prostaglandin catabolic process [2,3].
What genes are involved in regulation of prostaglandin catabolic process?
Genes such as SLCO2A1, HPGD, METTL3, AGO2 and PTGS2 have been implicated in prostaglandin catabolism or its regulation [1,2,4,5].
How is prostaglandin catabolism regulated?
It is regulated at multiple levels including transporter-mediated uptake, enzymatic activity, and post-transcriptional control by microRNAs and AU-rich elements [3,4,5].
Why is prostaglandin catabolism important in inflammation?
Catabolism determines the half-life of prostaglandins, thereby controlling the duration and intensity of inflammatory responses [2,6].
What diseases are linked to prostaglandin catabolism?
Diseases include inflammatory disorders, vascular permeability defects, renal dysfunction and metabolic syndrome [1,6,7].
How can CRISPR be used to study prostaglandin catabolism?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes involved in prostaglandin degradation [1,4,5].
What is the role of SLCO2A1 in prostaglandin catabolism?
SLCO2A1 transports prostaglandins into cells, making them available for degradation, and its structure and mechanism have been characterized [3,5].
How do microRNAs regulate prostaglandin catabolism?
MicroRNAs can target mRNAs encoding prostaglandin pathway components, affecting their stability and thus catabolic capacity.
What experimental models are used to study prostaglandin catabolism?
Models include CRISPR knockout cell lines, overexpression cells, transport assays and lipidomics [2,3,5].
What is the connection between prostaglandin catabolism and insulin sensitivity?
Inter-organ prostaglandin signaling regulated by m6A methylation in brown fat can affect systemic insulin sensitivity independently of UCP1.
Conclusion
GO:1905828, regulation of prostaglandin catabolic process, is a critical biological process that controls the lifetime and local concentration of prostaglandins. Its dysregulation is linked to inflammation, vascular disorders, renal physiology and metabolic disease [1,2,6,7]. Understanding its molecular players, such as SLCO2A1, HPGD and post-transcriptional regulators, provides opportunities for therapeutic intervention [3,4,5]. CRISPR-based models are powerful tools to dissect the causal roles of these genes. EDITGENE offers comprehensive services to support such research, from knockout and point-mutation cell lines to library screening and bioinformatics.
References
- 1. Xiao L et al.. 2024. m(6)A mRNA methylation in brown fat regulates systemic insulin sensitivity via an inter-organ prostaglandin signaling axis independent of UCP1.. Cell Metab 36(10):2207-2227.e9 PMID: 39255799
- 2. Oyesola OO et al.. 2021. Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions.. Eur J Immunol 51(10):2399-2416 PMID: 34396535
- 3. Schuster VL. 2002. Prostaglandin transport.. Prostaglandins Other Lipid Mediat 68-69:633-47 PMID: 12432949
- 4. Moore AE et al.. 2011. MicroRNA and AU-rich element regulation of prostaglandin synthesis.. Cancer Metastasis Rev 30(3-4):419-35 PMID: 22005950
- 5. Xia Z et al.. 2025. Structure and transport mechanism of the human prostaglandin transporter SLCO2A1.. Nat Commun 16(1):8124 PMID: 40885756
- 6. Horikami D et al.. 2020. [Prostanoids regulate vascular permeability].. Nihon Yakurigaku Zasshi 155(6):395-400 PMID: 33132257
- 7. Makhoul RG et al.. 1986. Renal prostaglandins.. J Surg Res 40(2):181-92 PMID: 3511324
- 8. Levi G et al.. 1998. Regulation of prostanoid synthesis in microglial cells and effects of prostaglandin E2 on microglial functions.. Biochimie 80(11):899-904 PMID: 9893949
